BOEHRINGER INGELHEIM FLOMAX APPROVAL MAKES PRODUCT THIRD ALPHA BLOCKER FOR BPH; LONG-TERM EUROPEAN/U.S. DATA SHOW CONTINUED EFFICACY IN BPH SYMPTOMS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".